# Arbutus Biopharma Corp: Form SC 13D, filed Sep 15, 2017

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: SC 13D
- Filed: 2017-09-15
- Accepted by EDGAR: Sep 14, 2017, 20:58 ET
- Period: not reported
- Accession: 0001193125-17-285465
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000119312517285465/d445331dsc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000119312517285465/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000119312517285465/d445331dsc13d.htm

Filed Sep 15, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-285465. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
